& shy; Mr. Fuzhou Fang’s high-risk lymphoma has added a cure guarantee. The treatment method comes from stem cells extracted from the placenta of the fetus whose wife just gave birth. The news was learned by the reporter yesterday from Professor Chen Zhizhe, the chief physician of hematology department of Union Hospital affiliated to Fujian Medical University. According to research, placenta stem cells can also treat many difficult diseases. & shy; Men suffer from lymphoma & shy; Need to rely on placenta to save life & shy; Due to repeated fever, Mr. Fang, 25, went to the hospital for examination and was diagnosed with “skin non-Hodgkin NK-T cell lymphoma” on February 12 “. This is a high-risk “blood cancer”, when his wife was already pregnant. & shy; However, the soon-to-be-born child has brought a turning point for Mr. Fang to cure the disease. After the child was born in March, Mr. Fang’s wife’s placenta was collected and retained, and it was prepared to prepare placenta stem cells within more than a month. It was possible that Mr. Fang could be used later after treatment. & shy; Professor Chen Zhizhe introduced that the current hematopoietic stem cell transplantation, commonly known as bone marrow transplantation. There are three commonly used sources, one is neonatal umbilical cord blood stem cell transplantation. However, the amount of umbilical cord blood stem cells is usually only enough for children with leukemia weighing about 30 kilograms once; Although adult patients also use umbilical cord blood, the quantity is insufficient, resulting in slow implantation and poor hematopoietic reconstruction; the second is matched or semi-matched bone marrow transplantation of immediate family members. Take Mr. Fang as an example. If he wants to use the bone marrow of this newborn baby, at least he will have to wait until the child is 10 years old to have an appropriate number of bone marrow stem cells. At the same time, patients also need to bear the risk of rejection after receiving allogenic stem cell transplantation; The third is the non-relative matching bone marrow donation of “Chinese Bone Marrow Bank. & shy; “The amount of hematopoietic stem cells in placenta is usually 5-10 times that of hematopoietic stem cells in umbilical cord blood, and both adult patients may be enough.” Professor Chen Zhizhe said that the cells that can be extracted from placenta by current technology include not only hematopoietic stem cells, but also placenta subpotent stem cells, placenta mesenchymal stem cells and placenta mother stem cells. Placenta subtotipotent stem cells and placenta mesenchymal stem cells can be transplanted together with hematopoietic stem cells, which can not only cure diseases, but also resist rejection of allogenic stem cell transplantation. & shy; Placenta stem cells & shy; Can treat a variety of diseases & shy; It is understood that this series of technologies for the extraction, identification and cultivation of embryonic stem cells are the first of Han Zhongchao, a foreign academician of French Academy of Medical Sciences and a part-time professor of Fujian Medical University. & shy; In 2013, the 301 Hospital of Beijing People’s Liberation Army applied the technology taught by Han Zhongchao to a 9-year-old girl suffering from aplastic anemia in Henan province. After the girl transplanted her sister’s placenta stem cells, the hematopoietic function returned to normal, and the health status was stable after a doctor’s follow-up for more than one year. Professor Han Zhongchao has won the first prize and the second prize of national scientific and technological progress for three times. & shy; Besides treating leukemia, placenta stem cells can also be used for immune system and treatment of various seemingly irreversible diseases. Its therapeutic principle originates from the function of “regeneration of cells and tissues”, that is, the category of “regenerative medicine. Professor Han Zhongchao mentioned in his team’s research paper that in a person’s life, all kinds of cells in the body need to be constantly updated, these metabolic tasks are accomplished by special cells such as stem cells. “If we can supplement our own stem cells, theoretically, it may prolong our life”. & shy; Professor Chen Zhizhe, a national expert, told the reporter that these placenta stem cells can be directionally differentiated to cultivate stem cells for treating various diseases, covering immune system, nervous system, digestive system, endocrine system, dermatology, solid tumors, blood diseases, cardiovascular diseases, organ and tissue injuries, etc., such as for the treatment of myocardial infarction, liver cirrhosis, diabetes, etc., and even have Beauty & Health efficacy. This technology has been widely recognized worldwide. & shy; At present, Professor Han Zhongchao has established a “stem cell bank” to receive placenta collection, extraction, identification and culture of placenta stem cells. Fuzhou’s business is carried out in the stem cell Medical Research Institute of Fujian Medical University. (Reporter Zhu Danhua)